FRANKFURT, Oct 23 (Reuters) - Roche on Wednesday
said that third-quarter sales gained a currency-adjusted 9% to
15.14 billion Swiss francs ($17.46 billion).
That surpassed an analysts' consensus estimate of 14.9
billion francs, based on LSEG data.
($1 = 0.8671 Swiss francs)